Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating
children with metastatic rhabdomyosarcoma or other malignant mesenchymal tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Societe Internationale d'Oncologie Pediatrique
Collaborators:
Children's Cancer and Leukaemia Group Societe Francaise Oncologie Pediatrique